Login to Your Account

European C21 BioVentures

'Aberrations In Value' Can Help Biotech Pull In Global Funding

By Brady Huggett

Monday, March 28, 2005

LONDON - Jonathan Kil, president and CEO of Sound Pharmaceuticals Inc., is looking for a considerable first round of funding - as much as $40 million, although that might be done in tranches, with a first closing for $10 million.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription